Fighting Blindness Canada

First Patients Dosed in Gene Therapy Trial for USH1B

AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial This trial...

Read More
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet...

Read More
Fighting Blindness Canada logo

Canada’s Vision Health Stakeholders Applaud Parliament’s Passage of Bill C-284, the National Strategy for Eye Care Act

The recent passage of Bill C-284, the National Strategy for Eye Care Act by the Government of Canada, marks a significant advancement in the...

Read More
Fighting Blindness Canada

Robotic Radiation Treatment May Help Treat Wet AMD

A new study, published in The Lancet, suggests that a one-time radiation therapy may reduce the number of anti-VEGF injections needed for wet...

Read More
Fighting Blindness Canada research

First Patients Treated in XLRP Gene Therapy Trial

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...

Read More